No Image Available

Cryoablation catheters

Freezor™ cardiac cryoablation catheter

<p>The Freezor™ cardiac cryoablation catheters are single-use catheters designed to ablate cardiac tissue by creating focal lesions.</p>

Ordering information
Contact a representative

Features

Freezor™ and Freezor Xtra™ catheters

Restoring life’s rhythm. Big and small.

Freezor™ and Freezor™ Xtra cardiac cryoablation catheters freeze the target tissue and block the electrical conduction by creating scar tissue. The catheters are designed to create focal lesions to treat (AVNRT) for both adult and pediatric† patients.

The Freezor™ Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias.

Freezor™ catheter details

  1. Tip length: 4 mm
  2. 2.5 mm
  3. 5 mm
  4. 2.5 mm
  5. Shaft: 7 Fr, 108 cm
This image shows the Freezor™ cardiac cryoablation catheter specifications.

Freezor™ Xtra catheter details

  1. Tip length: 6 mm 
  2. 2.5 mm 
  3. 5 mm 
  4. 2.5 mm 
  5. Shaft: 7 Fr, 108 cm
This image shows the Freezor™ Xtra cardiac cryoablation catheter specifications.

Clinical evidence

Proven. Predictable.

Freezor™ catheters are the only FDA-approved ablation catheters for the treatment of AVNRT in both pediatric† and adult patients. Patient outcomes include:

  • 0% of reported AVNRT cases resulted in permanent AV block1–16
  • 89% quality of life improvement after cryoablation1–16
  • ≥ 95% acute procedural success from AVNRT1–16
Download clinical evidence (open in new window)

Testimonial

The first of its kind

Hear from a pediatric electrophysiologist to learn more about the Freezor™ cardiac cryoablation catheters, the first and only FDA-approved devices for the treatment of both pediatric† and adult AVNRT.

Freezor™ MAX

Look no further.

The Freezor™ MAX cardiac cryoablation catheter is an adjunctive device used in the endocardial treatment of paroxysmal and persistent atrial fibrillation (episode duration less than six months) to complete pulmonary vein isolation (PVI), if needed. It may also be used for: 

  • Gap cryoablation to complete electrical isolation of the pulmonary veins 
  • Cryoablation of focal trigger sites 
  • Creation of ablation line between the inferior vena cava and the tricuspid valve

Freezor™ MAX catheter details

  1. Tip length: 8 mm 
  2. 3.5 mm 
  3. 5 mm 
  4. 2 mm 
  5. Shaft: 9 Fr, 90 cm
This image shows the Freezor™ MAX cardiac cryoablation catheter specifications.

Ordering information

Freezor™ cardiac cryoablation catheter

Item Number Description Tip length (mm) Electrode spacing (mm) Catheter diameter (Fr) Shaft length (cm) Recommended introducer (Fr) Reach (mm)
207F1 Short/red 4 2.5 – 5 – 2.5 7 108 8 47
207F3 Medium/blue 4 2.5 – 5 – 2.5 7 108 8 53
207F5 Long/orange 4 2.5 – 5 – 2.5 7 108 8 58

Freezor™ Xtra cardiac cryoablation catheter

Item Number Description Tip length (mm) Electrode spacing (mm) Catheter diameter (Fr) Shaft length (cm) Recommended introducer (Fr) Reach (mm)
217F1 Short/red 6 2.5 – 5 – 2.5 7 108 8 49
217F3 Medium/blue 6 2.5 – 5 – 2.5 7 108 8 55
217F5 Long/orange 6 2.5 – 5 – 2.5 7 108 8 60

Freezor™ MAX cardiac cryoablation catheter

Item Number Description Tip length (mm) Electrode spacing (mm) Catheter diameter (Fr) Shaft length (cm) Recommended introducer (Fr) Reach (mm)
209F3 Medium/blue 8 3.5 – 5 – 2.5 9 90 10 55
209F5 Long/orange 8 3.5 – 5 – 2.5 9 90 10 66

Similar products

† Indicated for patients over two years of age.

  1. Wells P, Dubuc M, Klein GJ, et al. Intracardiac ablation for atrioventricular nodal reentry tachycardia using a 6 mm distal electrode cryoablation catheter: Prospective, multicenter, North American study (ICY-AVNRT STUDY). J Cardiovasc Electrophysiol. 2018;29(1):167–176.
  2. Avari JN, Jay KS, Rhee EK. Experience and results during transition from radiofrequency ablation to cryoablation for treatment of pediatric atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2008;31(4):454–460.
  3. Beach C, Beerman L, Mazzocco S, Brooks MM, Arora G. Use of three-dimensional mapping in young patients decreases radiation exposure even without a goal of zero fluoroscopy. Cardiol Young. 2016;26(7):1297–1302.
  4. Chanani NK, Chiesa NA, Dubin AM, Avasarala K, Van Hare GF, Collins KK. Cryoablation for atrioventricular nodal reentrant tachycardia in young patients: predictors of recurrence. Pacing Clin Electrophysiol. 2008;31(9):1152–1159.
  5. Cokkinakis C, Avramidis D, Alexopoulos C, Kirvassilis G, Papagiannis J. Cryoablation of atrioventricular nodal reentrant tachycardia in children and adolescents: improved long-term outcomes with increasing experience. Hellenic J Cardiol. 2013;54(3):186–191.
  6. Drago F, Placidi S, Righi D, et al. Cryoablation of AVNRT in children and adolescents: early intervention leads to a better outcome. J Cardiovasc Electrophysiol. 2014;25(4):398–403.
  7. Drago F, Russo MS, Silvetti MS, Santis ADE, Iodice F, Onofrio MTN. Cryoablation of typical atrioventricular nodal reentrant tachycardia in children: six years' experience and follow-up in a single center. Pacing Clin Electrophysiol. 2010;33(4):475–481.
  8. Gist K, Tigges C, Smith G, Clark J. Learning curve for zero-fluoroscopy catheter ablation of AVNRT: early versus late experience. Pacing Clin Electrophysiol. 2011;34(3):264–268.
  9. Papagiannis J, Papadopoulou K, Rammos S, Katritsis D. Cryoablation versus radiofrequency ablation for atrioventricular nodal reentrant tachycardia in children: long-term results. Hellenic J Cardiol. 2010;51(2):122–126.
  10. Pieragnoli P, Paoletti Perini A, Checchi L, et al. Cryoablation of typical AVNRT: Younger age and administration of bonus ablation favor long-term success. Heart Rhythm. 2015;12(10):2125–2131.
  11. Qureshi MY, Ratnasamy C, Sokoloski M, Young ML. Low recurrence rate in treating atrioventricular nodal reentrant tachycardia with triple freeze-thaw cycles. Pacing Clin Electrophysiol. 2013;36(3):279–285.
  12. Reents T, Springer B, Ammar S, et al. Long-term follow-up after cryoablation for adolescent atrioventricular nodal reentrant tachycardia: recurrence is not predictable. Europace. 2012;14(11):1629–1633.
  13. Russo MS, Drago F, Silvetti MS, et al. Comparison of cryoablation with 3D mapping versus conventional mapping for the treatment of atrioventricular re-entrant tachycardia and right-sided paraseptal accessory pathways. Cardiol Young. 2016;26(5):931–940.
  14. Scaglione M, Ebrille E, Caponi D, et al. Single center experience of fluoroless AVNRT ablation guided by electroanatomic reconstruction in children and adolescents. Pacing Clin Electrophysiol. 2013;36(12):1460–1467.
  15. Young ML, Niu J. Using coronary sinus ostium as the reference for the slow pathway ablation of atrioventricular nodal reentrant tachycardia in children. J Arrhythm. 2020;36(4):712–719.
  16. Schwagten B, Knops P, Janse P, et al. Long-term follow-up after catheter ablation for atrioventricular nodal reentrant tachycardia: a comparison of cryothermal and radiofrequency energy in a large series of patients. J Interv Card Electrophysiol. 2011;30(1):55–61.